
Lung Power Peaks in Our 20s—and It's a Steady Decline From There, Study Finds
Scientists at the Barcelona Institute for Global Health (ISGlobal) led the study, published Thursday in The Lancet Respiratory Medicine. After analyzing data from earlier population studies, the researchers found that peak lung function is usually reached by our early 20s and—contrary to current wisdom—continues to steadily decline as we age.
According to lead author Judith Garcia-Aymerich, co-director of the Environment and Health over the Life Course program at ISGlobal, it's been assumed that our lungs follow a specific trajectory: they gradually get stronger until our mid-20s, reach a steady plateau over the next few decades, then decline as we reach middle age. But this assumption was based on studies that only examined lung function at certain time periods, rather than over the course of an entire life.
To bridge this knowledge gap, Garcia-Aymerich's team combined and analyzed data from eight different population studies in Europe and Australia. These studies collectively involved around 30,000 people from the ages of four to 82, and lung function was measured through forced spirometry, a test where people blow out as much air as possible after taking a deep breath.
The researchers first identified two broad stages of lung development: a phase of rapid growth in early childhood, followed by slower, steady growth through the early 20s. On average, this peak was reached around age 20 for women and age 23 for men. Unlike other research, they failed to find any evidence of a steady period of lung function following this peak.
'Previous models suggested a plateau phase until the age of 40, but our data show that lung function starts to decline much earlier than previously thought, immediately after the peak,' said Garcia-Aymerich in a statement released by ISGlobal.
The findings, somber as they are, might help improve how respiratory health is tracked and maintained, the researchers say.
They found that certain risk factors for poor lung health, such as asthma and smoking, might affect lung function a bit differently than suspected, for instance. Chronic asthma appears to weaken lung health at an early age, a weakness that then persists throughout a person's life. Smoking, on the other hand, seems to rapidly worsen a person's lungs starting in the mid-30s. Equipped with this knowledge, it might be possible to intervene early on, the researchers say.
'Early detection of low lung function may allow interventions to prevent chronic respiratory diseases in adulthood,' said Garcia-Aymerich.
While our lungs might not stay in tip-top shape as long as hoped, there are things most anyone can do to keep them as healthy as possible, such as regular physical exercise.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
1 Stock Down 40% This Year to Buy and Hold
Key Points Novo Nordisk's shares have been trending downward due to clinical setbacks and underwhelming results. However, the company has some potential catalysts on the way that could jolt its stock price. Novo Nordisk looks attractive given its lineup and pipeline, especially at current levels. 10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market. However, the Denmark-based drugmaker has given up most of these gains over the past year; the stock is down by 40% since January alone. Despite its recent misfortunes, Novo Nordisk's shares could still deliver strong returns to patient investors. Here's why. The weight management opportunity Novo Nordisk primarily develops medicines for diabetes and, in recent years, weight management. Its stock has plunged over the past year because its financial results haven't been as impressive as the market had hoped. It also faced some clinical setbacks, while its biggest rival in its core markets, Eli Lilly, earned some important wins. However, there's more to the story. The market for anti-obesity medications could grow at an incredibly rapid rate. Some analysts estimate that it will be worth $150 billion by 2035, compared to $15 billion last year. Novo Nordisk still has one of the deepest pipelines in the industry. In fact, it's challenging to find a company other than Eli Lilly that has more promising products. Recently, Novo Nordisk expanded its pipeline through various licensing deals. Here's one more thing that recently broke its way: Eli Lilly's oral GLP-1 candidate, orforglipron, did not perform nearly as well as expected in a phase 3 study. This opens the door for Novo Nordisk to catch up to its longtime rival. The company's oral version of Wegovy is currently awaiting approval from regulators in the U.S. The oral version led to an average weight reduction of 13.6% in a phase 3 clinical trial, slightly higher than the 12.4% that orforglipron recently posted in its late-stage study. While it's always hard to compare across clinical trials, the data at the very least suggests that oral Wegovy is comparable to orforglipron -- but only the former drug is closing in on approval. Novo Nordisk also has yet another promising anti-obesity candidate in phase 3 studies, amycretin, which the Denmark-based pharmaceutical giant is testing in both subcutaneous and oral formulations. Why is the race to develop an oral weight loss option so important? Pills are easier and cheaper to manufacture, store, and transport. So, compared to injectable weight loss therapies, oral versions would allow drugmakers to produce them more cost-effectively and to expand the reach of weight loss therapies. On top of that, some patients are strongly averse to needles. Because the current leading weight management drugs are administered subcutaneously, an oral option would likely take a decent share of the market. Novo Nordisk is likely to be first to market. And the company could follow up that win with another oral product in amycretin. The price is right Let's go back to Novo Nordisk's recent and disappointing financial results. In the first half of the year, revenue rose by 16% year over year to 154.9 billion Danish kroner ($24.2 billion), while net profit came in at 55.5 billion DKK ($8.7 billion). Perhaps that's not quite what the market expected to see, but these are still excellent results for a pharmaceutical giant -- most drugmakers of that size would be happy to grow their revenue at high-single-digit or low-double-digit rates. Meanwhile, the stock appears reasonably valued, trading at 13 times forward earnings, compared to the healthcare industry's average of 16.2. What's the verdict? Novo Nordisk looks attractive at current levels, given the company's strong pipeline in weight management and a lineup that continues to deliver consistent profits. Despite recent setbacks, the stock is well-positioned to deliver excellent results over the long term. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Prosper Junior Bakiny has positions in Eli Lilly and Novo Nordisk. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 1 Stock Down 40% This Year to Buy and Hold was originally published by The Motley Fool Sign in to access your portfolio


Fox News
2 hours ago
- Fox News
Francis Ford Coppola's treatment sheds light on heart condition affecting millions
Francis Ford Coppola, director of "The Godfather," was hospitalized in Italy last week for a non-emergency cardiac procedure. The filmmaker, 86, sought to update a "30-year-old AFib procedure," according to a post on his Instagram page. AFib, or atrial fibrillation (AFib), is an "irregular and often rapid heart rhythm" that can raise the risk of blood clots, heart failure, stroke and other heart-related complications, according to the American Heart Association. After Italian media sources reported the director's hospital visit, a representative for Coppola called it a "scheduled update procedure" and said he was "resting nicely." "All is well," according to his representatives. "Da Dada (what my kids call me) is fine," the director said on his social media, speaking for what appears to be the first time about his condition. He continued: "Taking an opportunity while in Rome to do the update of my 30-year-old AFib procedure with its inventor, a great Italian doctor — Dr. Andrea Natale! I am well!" Dr. Bradley Serwer, an interventional cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company, spoke with Fox News Digital about the condition. "AFib is typically not immediately life-threatening, but it can lead to complications or issues in the future," said the cardiologist, who has not treated Coppola. With AFib, the normal electrical activity in the heart changes to chaotic electrical signals, according to the Maryland-based cardiologist. This causes the heart to beat quickly and get out of rhythm. Instead of contracting normally, the upper chambers of the heart — called atria — start to quiver, causing blood clots to form. "When these clots break free, they can travel to the brain, causing a stroke," Serwer cautioned. For many people, AFib may have no symptoms, but for some, it can cause a fast or pounding heartbeat, shortness of breath or lightheadedness. "AFib can be challenging due to its diverse manifestations," Serwer noted. There are several procedural approaches to treat atrial fibrillation, according to the cardiologist. The most common procedure is called an ablation, which is when a specialized cardiologist uses catheters to follow the heart's electrical activity. The doctor then burns the sites where the AFib begins. "This procedure has a high rate of success and complications are low, making it a highly valued option," Serwer noted. If a patient is undergoing open-heart surgery for coronary artery disease or valvular heart disease, a surgeon can perform a "maze procedure," which creates a "maze-like pattern of scar tissue" in the upper chambers of the heart to block irregular electrical signals, according to Mayo Clinic. There are also procedures to reduce the risk of stroke in patients who have AFib, but who may not be able to take blood thinners. By placing a small device where blood clots form, the rate of stroke drops significantly, Serwer said. In some cases of atrial fibrillation, the condition can come and go, but other patients may experience persistent AFib, the cardiologist said. For more Health articles, visit While it's not usually life-threatening, AFib is still considered a serious medical condition that requires proper treatment. Serwer advised, "If you experience sudden-onset dizziness or palpitations that persist, it is imperative to seek immediate evaluation from a medical professional."


CNET
3 hours ago
- CNET
What Exercise Burns the Most Calories? We Ranked Them to Find Out
It's no secret that burning more calories than you eat is the best way to lose weight. The best way to achieve that is to exercise regularly to increase your calorie expenditure. But not all exercises are created equal and some burn more calories than others. That means that knowing the best workout for your weight loss goals is vital. It's no good forcing yourself onto the exercise bike every morning if it isn't going to get the job done. The best way to gauge calories burned is by employing an accurate heart rate monitor. Such monitors take into account your personal statistics like age, sex, weight and height. Whether you use a heart rate monitor or a different type of fitness tracker, it's still good to have an idea of how many calories the most common exercises burn. Keep reading to find out how many calories typical exercises can burn and how to figure out your calorie burn during workouts. What factors affect calorie burn during exercise? Professional fitness trainer Brooke Taylor explains that the main factors that differentiate the number of calories burned during exercise include: Heart rate training zone You'll want to figure out your target heart rate and your maximum heart rate zones to make sure you're working hard enough when exercising aerobically. Knowing your target heart rate training zone gives you a tactile number instead of going by feel, and it will help you build a solid base and endurance without burning you out. Resting heart rate A normal resting heart rate is between 60 and 100 beats per minute. Knowing your resting heart rate is important to make sure your heart is operating in a healthy manner while at rest. The higher the resting heart rate is, the more it's indicative that your stress levels or other underlying health problems may be at play. Weight In general, the more you weigh, the more calories you will burn during exercise. This is because you are working with more body mass and require more energy compared to someone lighter. Types of exercise Cardio-based workouts burn more calories than other types of workouts like strength training or yoga. What exercise burns the most calories? Even though everyone is different, there are general estimates for how many calories you can burn when you exercise. The estimates below are calculated based on someone who weighs 130 pounds through the American Council on Exercise calculator. You can use that calculator to get a close estimate of how many calories you would burn daily during many common activities. Running for 30 minutes burns about 206 calories. Getty Images 1. Running/jogging 206 calories per 30 minutes Running at even a slow pace burns a lot of calories for 30 minutes. On average, running burns between 10.8 to 16 calories per minute, putting it at the top of the list of workouts that burn the most calories. To up the calorie burn, increase the intensity or add in sprint intervals. 2. Hiking 176 calories per 30 minutes Hiking is one of the best ways to escape to the outdoors, turn off technology and get in some movement. And because you're not walking on a level path like down the street, navigating different terrains or hills challenges more muscles, so you burn more calories. 3. Biking/cycling 5.5 mph117 calories per 30 minutes If you're an avid biker, you may go faster than 5.5 mph but if you tend to bike at a leisurely pace, you can still burn 117 calories per 30 minutes. Note that this is different than if you do high-intensity interval training or classes on spin bikes. 4. Jump rope (fast pace) 115 calories per 10 minutes Let out your inner kid and take up jump rope for a surprisingly fast way to burn a ton of calories. Just 10 minutes of jumping rope burns 115 calories. Walking is a simple exercise that can help you burn calories. Getty Images 5. Walking (moderate pace) 97 calories per 30 minutes Walking is the simplest and most accessible form of exercise. And if you're anything like me, you rely on walks for much-needed breaks during the day. Even if you don't walk for 30 minutes or longer on every walk, all of the short walks you take add up. 6. Weightlifting88 calories per 30 minutes Although not the quickest way to burn calories, lifting weights increases strength and muscle tone and enhances metabolism. The more muscle mass you have, the more calories you burn at rest. 7. Stretching/Hatha yoga Getty/Halfpoint Images 73 calories per 30 minutes While stretching or restorative yoga may not burn a ton of calories, it still warrants a well-deserved spot in your weekly workout lineup for enhanced mobility, flexibility, recovery and tension relief. Exercises compared Below is an example of calories burned per exercise based on the American Council on Exercise (ACE) calculator for a 130-pound person. Please keep in mind, these numbers will change based on weight, muscle mass and body composition, the type of workout, age and gender. Exercise Time Calories Time Calories Time Calories Running/Jogging 10 mins 68 30 mins 206 1 hour 412 Hiking 10 mins 58 30 mins 176 1 hour 353 Biking/Cycling (5.5 mph) 10 mins 39 30 mins 117 1 hour 235 Jump rope (fast pace) 10 mins 117 30 mins 353 1 hour 707 Walking (moderate) 10 mins 32 30 mins 97 1 hour 194 Weight Training (normal) 10 mins 29 30 mins 88 1 hour 176 Stretching/Hatha Yoga 10 mins 24 30 mins 73 1 hour 147 How to track calories burned Although most people use smartwatches like the Apple Watch or other types of wearables that can track the number of calories they burn daily, it's important to know that they aren't always accurate. Research has shown that there are discrepancies with these figures, so take the information it collects as a guesstimate instead. Heart rate monitors and similar devices are more reliable for taking your heart rate reading, if that's something you like to track as well. However, if you're interested in having an idea of the number of calories burned, you can do so by wearing a smartwatch or try out free trackers online like and